Skip to main content
SpringerLink
Log in

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

  • Original Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Cancer patients receiving chemotherapy are prone to develop infections that might postpone treatment and lead to complications. The aim of our study was to investigate whether a heterogeneous population of patients with solid tumors and malignant lymphoma undergoing chemotherapy would respond serologically to vaccination against influenza and pneumococcal disease. There are no established routines in oncology departments in Norway regarding vaccination of these patients. The study included 35 cancer patients with median age 53 yr (range 20–74) and 38 controls with median age 57 yr (range 43–75). The chemotherapy regimens used were mild or moderately immunosuppressive. After one vaccination, 25 patients (72%) and 34 controls (87%) were serologically protected against two or three influenza strains. A higher proportion of patients with solid tumors (81%) than lymphoma (38%) achieved protection. Age, months on chemotherapy, and curative versus palliative treatment did not influence responses to vaccination. After vaccination with a 23-valent polysaccharide vaccine against pneumococci, most patients and controls achieved protective serum levels of antibodies against the different serotypes, with the exception that fewer patients were protected against serotype 4. The responses in controls were, however, generally stronger to all serotypes. Tumor type did not influence this vaccination response. We conclude that our cancer patients achieved adequate responses to influenza virus and Streptococcus pneumoniae. These are not live vaccines and are therefore safe for immunocompromised patients. Routine vaccinations against influenza virus and Streptococcus pneumoniae should be considered in cancer patients undergoing mild to moderately immunosuppressive chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2000). Prevention and control of influenza. MMWR 49(RR03):1–38.

    Google Scholar 

  2. Pizzo, P. A. (1999). Fever in immunocompromized patients. N. Engl. J. Med. 341:893–900.

    Article  PubMed  CAS  Google Scholar 

  3. Ljungman, P., et al. (1995). Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow transplantation. Bone Marrow Transplant. 15:455–460.

    PubMed  CAS  Google Scholar 

  4. Ljungman, P. (1999). Immunization of transplant recipients. Editorial Bone Marrow Transplant. 23:635–636.

    Article  CAS  Google Scholar 

  5. Norwegian Institute of Public Health. (1998). Veiledning om vaksinasjon 1998 (Guidelines for Vaccination 1998) (H. Nøkleby, ed). Norwegian Institute of Public Health, Oslo.

    Google Scholar 

  6. Anderson, H., et al. (1994). Seroconversion after influenza vaccination in patients with lung cancer. Br. J. Cancer 80:219–222.

    Article  Google Scholar 

  7. Brydak, L. B. and Calbecka, M. (1999). Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leukemia Lymphoma 32:369–374.

    PubMed  CAS  Google Scholar 

  8. Robertson, J. D., et al. (2000). Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenza type B in patients with multiple myeloma. Br. J. Cancer 82:1261–1265.

    Article  PubMed  CAS  Google Scholar 

  9. Kempe, A., Hall, C. B., MacDonald, N. E. and Foye, H. R. (1989). Influenza in children with cancer. J. Pediatr. 115:33–39.

    Article  PubMed  CAS  Google Scholar 

  10. Ortbals, D. W., et al. (1977). Influenza immunization of adult patients with malignant diseases. Ann. Intern. Med. 87:552–557.

    PubMed  CAS  Google Scholar 

  11. World Health Organization. (1982). Concepts and Procedures for Laboratory-Based Influenza Surveillance, ppB17-B35, World Health Organization, Geneva.

    Google Scholar 

  12. Aaberge, I. S., et al. (1996). Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors. Clin. Exp. Immunol. 105:12–17.

    Article  PubMed  CAS  Google Scholar 

  13. Stack, A. M., et al. (1998). Minimum protective serum concentrations of penumococcal anticapsular antibodies in infant rats. J. Infect. Dis. 177:986–990.

    PubMed  CAS  Google Scholar 

  14. Salsbury, D. M. and Begg, N. T., ed. (1996). Department of Health Immunisation Against Infectious Disease, pp113–120, HMSO, London.

    Google Scholar 

  15. Chisholm, J. C., Devine, T., Charlett, A., Pinkerton, C. R. and Zambon, M. (2001). Response to influenza immunisation during treatment for cancer. Arch. Dis. Child. 84:496–500.

    Article  PubMed  CAS  Google Scholar 

  16. Schildt, R. A., Luedeke, D. W., Kasai, G., El-Beheri, S. and Laham, M. N. (1979). Antibody response to influenza immunization in adult patients with malignant disease. Cancer 44:1629–1635.

    Article  Google Scholar 

  17. Clerici, M., et al. (1994). Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin’s disease. Eur. J. Cancer 30:1464–1470.

    Article  Google Scholar 

  18. Lo, W., et al. (1993). Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur. J. Clin. Microbiol. Infect. Dis. 12:778–782.

    Article  PubMed  CAS  Google Scholar 

  19. Minutello, M., et al. (1999). Safety and immunogenecity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunised for three consecutive influenza seasons. Vaccine 17:99–104.

    Article  PubMed  CAS  Google Scholar 

  20. Pauksen, K., et al. (2000). Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin. Infect. Dis. 30:342–348.

    Article  PubMed  CAS  Google Scholar 

  21. Babai, I., et al. (2001). A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuramidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains. Vaccine 20(3–4):505–515.

    Article  PubMed  CAS  Google Scholar 

  22. Neirynck, S., et al. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5:1157–1163.

    Article  PubMed  CAS  Google Scholar 

  23. Sankilampi, U., Honkanen, P. O., Bloigu, A., Herva, E. and Leinonen, M. (1996). Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J. Infect. Dis. 173:387–393.

    PubMed  CAS  Google Scholar 

  24. Rubins, J. B., Alter, M., Loch, J. and Janoff, E. N. (1999). Determination of antibody responses of elderly to all 23 capsular polysaccharides after pneumococcal vaccination. Infect. Immun. 67:6979–5984.

    Google Scholar 

  25. Hartkamp, A., Mulder, A. H. L., Rijkers, G. T., van Velzen-Blad, H. and Biesma, D. H. Anitbody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukemia. Vaccine 19:1671–1677.

  26. Molrine, D. C., et al. (1995). Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin’s disease. Ann. Intern. Med. 123:828–834.

    PubMed  CAS  Google Scholar 

  27. Giebink, G. S. (2001). The prevention of pneumococcal disease in England. N. Engl. J. Med. 16:1177–1183.

    Article  Google Scholar 

  28. Chan, C. Y., et al. (1996). Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin’s disease. J. Infect. Dis. 173:256–258.

    PubMed  CAS  Google Scholar 

  29. Wizeman, T. M., et al. (2001). Use of whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 69:1593–1598.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Immunology and Transfusion Medicine, University Hospital of Tromsø, Tromsø, Norway

    Anne Husebekk

  2. Department of Vaccinology, National Institute of Public Health, Oslo, Norway

    Ingeborg S. Aaberge

  3. Department of Virology, National Institute of Public Health, Oslo, Norway

    Helvi H. Samdal

  4. Skansen General Practitioners Office, Tromsø, Norway

    Svein Steinert & Hasse Melby

  5. Department of Oncology, University Hospital of Tromsø, 9038, Tromsø, Norway

    Tone Nordøy & Arne Kolstad

Authors
  1. Tone Nordøy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ingeborg S. Aaberge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Husebekk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Helvi H. Samdal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Svein Steinert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hasse Melby
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arne Kolstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tone Nordøy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nordøy, T., Aaberge, I.S., Husebekk, A. et al. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae . Med Oncol 19, 71–78 (2002). https://doi.org/10.1385/MO:19:2:71

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MO:19:2:71

Key Words

Search

Navigation